These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27538362)

  • 21. Analysis of a pharmacist-led adverse drug event management model for pharmacovigilance in an academic medical center hospital in China.
    He W; Yao D; Hu Y; Dai H
    Ther Clin Risk Manag; 2018; 14():2139-2147. PubMed ID: 30464487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.
    Eddy K; Jordan Z; Stephenson M
    JBI Database System Rev Implement Rep; 2016 Apr; 14(4):96-137. PubMed ID: 27532314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.
    Jha AK; Kuperman GJ; Teich JM; Leape L; Shea B; Rittenberg E; Burdick E; Seger DL; Vander Vliet M; Bates DW
    J Am Med Inform Assoc; 1998; 5(3):305-14. PubMed ID: 9609500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Authenticity and credibility aware detection of adverse drug events from social media.
    Hoang T; Liu J; Pratt N; Zheng VW; Chang KC; Roughead E; Li J
    Int J Med Inform; 2018 Dec; 120():157-171. PubMed ID: 30409341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Authenticity and credibility aware detection of adverse drug events from social media.
    Hoang T; Liu J; Pratt N; Zheng VW; Chang KC; Roughead E; Li J
    Int J Med Inform; 2018 Dec; 120():101-115. PubMed ID: 30409335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse drug event nonrecognition in emergency departments: an exploratory study on factors related to patients and drugs.
    Roulet L; Ballereau F; Hardouin JB; Chiffoleau A; Potel G; Asseray N
    J Emerg Med; 2014 Jun; 46(6):857-64. PubMed ID: 24565882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies.
    Winnenburg R; Sorbello A; Ripple A; Harpaz R; Tonning J; Szarfman A; Francis H; Bodenreider O
    J Biomed Inform; 2015 Oct; 57():425-35. PubMed ID: 26342964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population?
    Green JL; Hawley JN; Rask KJ
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):31-9. PubMed ID: 17608245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extraction of Information Related to Drug Safety Surveillance From Electronic Health Record Notes: Joint Modeling of Entities and Relations Using Knowledge-Aware Neural Attentive Models.
    Dandala B; Joopudi V; Tsou CH; Liang JJ; Suryanarayanan P
    JMIR Med Inform; 2020 Jul; 8(7):e18417. PubMed ID: 32459650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing the effectiveness of computerized adverse drug event monitoring systems to enhance clinical decision support for hospitalized patients.
    Petratos GN; Kim Y; Evans RS; Williams SD; Gardner RM
    Appl Clin Inform; 2010; 1(3):293-303. PubMed ID: 23616843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a Web-Based System to Report Medication-Related Adverse Effects: Design and Usability Study.
    Lim R; Thornton C; Stanek J; Ellett LK; Thiessen M
    JMIR Form Res; 2022 Oct; 6(10):e37605. PubMed ID: 36206034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designing adverse event forms for real-world reporting: participatory research in Uganda.
    Davies EC; Chandler CI; Innocent SH; Kalumuna C; Terlouw DJ; Lalloo DG; Staedke SG; Haaland A
    PLoS One; 2012; 7(3):e32704. PubMed ID: 22479335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting.
    Linder JA; Haas JS; Iyer A; Labuzetta MA; Ibara M; Celeste M; Getty G; Bates DW
    Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1211-5. PubMed ID: 21155192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilot testing of checklists to discern adverse drug reactions and adverse drug events.
    Chen AM; Kiersma ME; Shepler BM; Murawski MM
    J Am Pharm Assoc (2003); 2013; 53(1):61-9. PubMed ID: 23636158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using Electronic Health Records to Identify Adverse Drug Events in Ambulatory Care: A Systematic Review.
    Feng C; Le D; McCoy AB
    Appl Clin Inform; 2019 Jan; 10(1):123-128. PubMed ID: 30786301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancing Medication Safety: Establishing a National Action Plan for Adverse Drug Event Prevention.
    Harris Y; Hu DJ; Lee C; Mistry M; York A; Johnson TK
    Jt Comm J Qual Patient Saf; 2015 Aug; 41(8):351-60. PubMed ID: 26215524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a computer-based adverse-drug-event monitor.
    Hwang SH; Lee S; Koo HK; Kim Y
    Am J Health Syst Pharm; 2008 Dec; 65(23):2265-72. PubMed ID: 19020194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Literature Review of Factors Influencing Medication Safety in Nursing Homes: Using a Systems Model.
    Al-Jumaili AA; Doucette WR
    J Am Med Dir Assoc; 2017 Jun; 18(6):470-488. PubMed ID: 28242191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse drug event-related emergency department visits associated with complex chronic conditions.
    Feinstein JA; Feudtner C; Kempe A
    Pediatrics; 2014 Jun; 133(6):e1575-85. PubMed ID: 24843054
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.